Fig. 7 | Scientific Reports

Fig. 7

From: SLC45A2 drives prostate cancer progression through tumor promotion and immune suppression

Fig. 7

IHC and correlation analysis of SLC45A2 with AMACR and ALB. (A) Bar plot of GO biological process enrichment. (B) Bar plot of KEGG pathway enrichment 21,22,23,24,25. Copyright permission of KEGG pathway maps our manuscript has been obtained. (C–D) mRNA expression correlation analysis of SLC45A2 with AMACR and ALB based on TCGA transcriptomic data. (E) Protein expression correlation analysis of SLC45A2 with AMACR and ALB based on HPA immunohistochemistry data.

Back to article page